On June 1st, the US biotech company Debut announced the completion of a $34 million Series B funding round. The round was led by BOLD (Business Opportunities for L’Oréal Development), the venture capital fund of French beauty company L’Oréal, which also acquired a minority stake.
Other investors participating in the round include Fine Structure Ventures, Material Impact, GS Futures, Cavallo Ventures, Cultivian Sandbox Ventures, ACVC Partners, and additional backers.
Founded in 2019 and headquartered in San Diego, California, Debut is a vertically integrated synthetic biolo …
